Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Cilostazol CR by Genovate Biotechnology for Intermittent Claudication: Likelihood of Approval
Cilostazol CR is under clinical development by Genovate Biotechnology and currently in Phase I for Intermittent Claudication. According to GlobalData,...